Risk modeling for esophageal cancer based on adaptive Lasso and Cox regression

IntroductionEsophageal cancer (EC) is one of the most aggressive tumor types worldwide, and malnutrition is extremely common among EC patients. By identifying EC biomarkers and conducting risk assessments on patients, more accurate diagnosis and treatment plans can be developed to prolong patients’...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaoli Li, Gaoyong Han, Yudan Yang, Enhao Liang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-08-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1609540/full
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:IntroductionEsophageal cancer (EC) is one of the most aggressive tumor types worldwide, and malnutrition is extremely common among EC patients. By identifying EC biomarkers and conducting risk assessments on patients, more accurate diagnosis and treatment plans can be developed to prolong patients’ survival.MethodsThis study developed a risk assessment model for post-surgical EC patients using clinical data from patients who underwent esophagectomy. Prognostic factors influencing survival were evaluated using Adaptive Lasso for variable selection, followed by Cox proportional hazards regression and Receiver Operating Characteristic (ROC) curve. Among multiple clinical variables, the International Normalized Ratio (INR) emerged as the most significant predictor of survival.ResultsElevated INR levels were significantly associated with improved 3-year and 5-year survival outcomes compared to the Prognostic Nutritional Index (PNI). Patients with higher INR exhibited notably better postoperative survival rates. Further analysis demonstrated that INR was significantly correlated with the final differentiation degree, final infiltration degree, and final positive/negative status of EC.DiscussionINR serves as a valuable and independent prognostic biomarker for postoperative survival assessment in EC patients. Incorporating INR into clinical risk models can enhance the accuracy of prognosis and assist clinicians in optimizing individualized therapeutic strategies for surgical EC patients.
ISSN:2234-943X